Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Communication with Sponsors and CROs

Posted on By

Standard Operating Procedure for Sponsor and CRO Communication

Purpose

This SOP outlines the procedures for communication with sponsors and Contract Research Organizations (CROs) in clinical trials and clinical studies. The goal is to establish clear, efficient, and effective communication channels to support study execution, monitoring, and reporting.

Scope

This SOP applies to all personnel involved in communicating with sponsors and CROs in clinical trials and clinical studies, including principal investigators, clinical research coordinators, and other study staff.

Responsibilities

  • Principal Investigator (PI): Leads communication with sponsors and CROs, ensuring study execution aligns with the sponsor’s and CRO’s expectations.
  • Clinical Research Coordinators: Assist in coordinating communication with sponsors and CROs and maintaining documentation.
  • Study Staff: Support communication efforts and provide updates to sponsors and CROs as necessary.
See also  SOP for Blinding and Masking

Procedure

  • Establishing Communication Channels:
    • Identify appropriate points of contact at the sponsor and CRO.
    • Set up regular communication schedules, including meetings, calls, and emails, to provide updates and discuss study progress.
  • Sharing Study Progress:
    • Provide updates on study progress, including enrollment, data collection, and safety monitoring, as agreed upon with the sponsor and CRO.
    • Share any issues or concerns that may impact the study’s success or compliance with regulatory requirements.
  • Collaboration and Problem-Solving:
    • Work collaboratively with the sponsor and CRO to resolve any issues that arise during the study.
    • Provide timely and accurate
information to assist in decision-making and problem-solving.
  • Documentation and Record-Keeping:
    • Maintain records of communication with the sponsor and CRO, including meeting minutes, emails, and phone call summaries.
    • Keep track of any agreements, decisions, or action items discussed during communication.
  • Continuous Improvement:
    • Gather feedback from the sponsor and CRO on the communication process and make improvements as necessary.
    • Adapt communication strategies to align with the sponsor’s and CRO’s expectations and study needs.
  • Abbreviations Used

    • SOP: Standard Operating Procedure
    • PI: Principal Investigator
    • CRO: Contract Research Organization

    Documents

    • Communication logs and meeting minutes
    • Agreements and action items from sponsor and CRO meetings
    • Correspondence with sponsors and CROs

    References

    • Regulatory guidelines for communication with sponsors and CROs
    • Institutional policies for communication management

    SOP Version

    Version: 1.0

    See also  SOP for Use of Placebos and Comparator Products
    Clinical Studies Tags:Adverse event reporting, Clinical data management, Clinical data validation, Clinical research compliance, Clinical research coordination, Clinical site selection, clinical studies, clinical study, Clinical study protocols, Clinical trial management, Clinical trial monitoring, Clinical trial participants, Clinical trial procedures, Clinical trial SOPs, clinical trials, Conflict of interest management, Data collection methods, Data management SOPs, eCRF validation, Electronic record-keeping guidelines, Electronic systems validation, Ethics committee reporting, Investigator training protocols, Participant data privacy, Participant recruitment strategies, Pharmacovigilance protocols, Quality assurance practices, Regulatory compliance procedures, Risk management procedures, Safety monitoring procedures, Site selection criteria, Study protocol development

    Post navigation

    Previous Post: SOP for Handling Complaints and Feedback
    Next Post: SOP for Validation and Qualification of Electronic Systems

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version